SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001641172-20-000032
Filing Date
2020-11-04
Accepted
2020-11-04 16:14:34
Documents
12
Period of Report
2020-11-02
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 77491
  Complete submission text file 0001641172-20-000032.txt   259285

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE mtnb-20201102.xsd EX-101.SCH 3210
3 XBRL LABEL FILE mtnb-20201102_lab.xml EX-101.LAB 35273
4 XBRL PRESENTATION FILE mtnb-20201102_pre.xml EX-101.PRE 23162
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3953
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38022 | Film No.: 201286856
SIC: 2834 Pharmaceutical Preparations